Skip to main content

Animations

MJFF Publications

5341 - 5350 of 9034 Results
Title
Year
  • Year
  • 2019
  • 2018
  • 2017
  • 2017
  • 2025
  • 2026
  • 2020
  • 2015
  • 2015
  • 2023
  • Summary Details
    OPEN
    Title: Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection
    Journal Name: Cell Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41422-019-0153-8
    Citation Count: 70
  • Summary Details
    OPEN
    Title: Mitochondrial Stasis Reveals p62-Mediated Ubiquitination in Parkin-Independent Mitophagy and Mitigates Nonalcoholic Fatty Liver Disease
    Journal Name: Cell Metabolism
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.cmet.2018.06.014
    Citation Count: 279
  • Trial of dextromethorphan/quinidine to treat levodopa‐induced dyskinesia in Parkinson's disease
    2017
    Summary Details
    RESTRICTED
    Title: Trial of dextromethorphan/quinidine to treat levodopa‐induced dyskinesia in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26976
    Citation Count: 35
  • Summary Details
    OPEN
    Title: The End Is the Beginning: Parkinson’s Disease in the Light of Brain Imaging
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2017.00330
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Extracellular Vesicles and B Cell Interactions: B-Side Track or Greatest Hit?
    Journal Name: ACS Nano
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1021/acsnano.5c07444
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Regulation between LRRK2 and PP2A signaling in cellular models of Parkinsons disease
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1042/bcj20260194
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Human plasma biomarker responses to inhalational general anaesthesia without surgery
    Journal Name: British Journal of Anaesthesia
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bja.2020.04.085
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Targeting β-arrestin2 in the treatment ofl-DOPA–induced dyskinesia in Parkinson’s disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1502740112
    Citation Count: 107
  • Summary Details
    OPEN
    Title: Which figure copy test is more sensitive for cognitive impairment in Parkinson's disease: Wire cube or interlocking pentagons?
    Journal Name: Clinical Neurology and Neurosurgery
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.clineuro.2015.10.019
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Genetic associations with age at dementia onset in the PSEN1 E280A Colombian kindred
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.13021
    Citation Count: 19
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.